Department of Ophthalmology, Hadassah Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120001, Israel.
Department of Military Medicine and "Tzameret," Faculty of Medicine, Hebrew University of Jerusalem and Medical Corps, Israel Defense Forces, Jerusalem 9112102, Israel.
Cold Spring Harb Perspect Med. 2024 Feb 1;14(2):a041277. doi: 10.1101/cshperspect.a041277.
One of the considerations in planning the development of novel therapeutic modalities is disease prevalence that is usually defined by studying large national/regional populations. Such studies are rare and might suffer from inaccuracies and challenging clinical characterization in heterogeneous diseases, such as inherited retinal diseases (IRDs). Here we collected reported disease prevalence information on various IRDs in different populations. The most common IRD, retinitis pigmentosa, has an average disease prevalence of ∼1:4500 individuals, Stargardt disease ∼1:17,000, Usher syndrome ∼1:25,000, Leber congenital amaurosis ∼1:42,000, and all IRDs ∼1:3450. We compared these values to genetic prevalence (GP) calculated based on allele frequency of autosomal-recessive IRD mutations. Although most values did correlate, some differences were observed that can be explained by discordant, presumably null mutations that are likely to be either nonpathogenic or hypomorphic. Our analysis highlights the importance of performing additional disease prevalence studies and to couple them with population-dependent allele frequency data.
在规划新型治疗方法的开发时,需要考虑疾病的流行率,这通常是通过研究大规模的国家/地区人群来定义的。这种研究很少,并且可能存在不准确的情况,并且在遗传性视网膜疾病(IRDs)等异质性疾病中存在具有挑战性的临床特征。在这里,我们收集了不同人群中各种 IRD 的报告疾病流行率信息。最常见的 IRD 是色素性视网膜炎,其平均疾病流行率约为每 4500 人中有 1 例,Stargardt 病为每 17000 人中有 1 例,Usher 综合征为每 25000 人中有 1 例,Leber 先天性黑矇为每 42000 人中有 1 例,所有 IRD 为每 3450 人中有 1 例。我们将这些值与基于常染色体隐性 IRD 突变等位基因频率计算的遗传流行率(GP)进行了比较。尽管大多数值确实相关,但观察到了一些差异,这些差异可以用可能是非致病性或低效的不一致、假定的无效突变来解释。我们的分析强调了进行额外的疾病流行率研究的重要性,并将其与依赖于人群的等位基因频率数据相结合。